Breaching the Fortress of Tumor Microenvironment to Control Cancer Metastasis
Aayami Jaguri1,2, Aamir Ahmad2,3,4,5
1Weill Cornell Medicine-Qatar, Doha 24811, Qatar.
Cancers
|September 28, 2023
Abstract:
As the primary cause of death for >90% of cancers, metastasis is the fourth and final stage of cancer during which cells gain the ability to leave their primary site, invade surrounding tissues, and disseminate to distant organs [...].
Insights
Metastasis, the spread of cancer cells, is the main cause of cancer death. Understanding this complex process is crucial for developing new treatments and improving patient outcomes.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Metastasis is the primary driver of cancer mortality, accounting for over 90% of cancer deaths.
- This complex process involves cancer cells detaching from the primary tumor, invading local tissues, and spreading to distant organs.
- Understanding the mechanisms of metastasis is critical for developing effective cancer therapies.
Discussion:
- The abstract highlights the critical role of metastasis in cancer progression and lethality.
- It underscores the need for further research into the cellular and molecular events driving cancer cell dissemination.
- Identifying therapeutic targets within the metastatic cascade is a key challenge in oncology.
Key Insights:
- Metastasis is the deadliest stage of cancer, responsible for the vast majority of cancer-related deaths.
- Cancer cells must acquire specific abilities to detach, invade, and travel to new sites in the body.
- Research into metastasis is vital for improving survival rates in cancer patients.
Outlook:
- Future research will focus on unraveling the intricate pathways that enable cancer cells to metastasize.
- Developing targeted therapies to inhibit metastasis holds significant promise for improving cancer treatment outcomes.
- A deeper understanding of metastasis could lead to earlier detection and more effective interventions for advanced cancers.
Related Concept Videos
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


